- , Stock Quote, Analysis, Rating and News" />
Showcases Stock ranks

  0 (0%)
Open: Pre. Close:
High: Low:
Volume: Market Cap: 0M
Ra Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It discovers and develops therapeutics for the treatment of diseases caused by excessive or uncontrolled activation of the complement system.
Prices Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: - -
Low: - -
Close: - -
Stock Technical Analysis
Target: Six months:
One year:
Support: Support1:
Resistance: Resistance1:
Moving Averages: MA(5):
MACD: MACD(12,26):
%K %D: %K(14,3):
RSI: RSI(14):
52-Week: High:
Average Vol(K): 3-Month:
Price, MAs and Bollinger Bands

Stock chart
Stock News
Wed, 01 Apr 2020
How Ra Pharmaceuticals (RARX) Stock Stands Out in a Strong Industry - Yahoo Finance

Thu, 11 Jun 2020
Alexion Pharmaceuticals: Patent Resolution Is Too Little Too Late - Seeking Alpha

Thu, 10 Oct 2019
Ra Pharmaceuticals (RARX) to be Acquired by UCB at $48/Sh - StreetInsider.com

Mon, 29 Jun 2020
Hedge Funds Aren’t Crazy About UMB Financial Corporation (UMBF) Anymore - Yahoo Finance

Thu, 10 Oct 2019
BBBY, FSCT, PCG and RARX among midday movers - Seeking Alpha

Thu, 02 Apr 2020
$RARX UCB Acquires Ra Pharmaceuticals And Updates 2020 Financial Guidance - CML News

Financial Analysis
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company's ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Stock Basics & Statistics
Exchange:  NASDAQ Global Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M)
Shares Float (M)
% Held by Insiders
% Held by Institutions
Shares Short (K)
Shares Short Prior Month (K)
Stock Financials
Book Value (p.s.)
Profit Margin
Operating Margin
Return on Assets (ttm)
Return on Equity (ttm)
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M)
Levered Free Cash Flow (M)
Stock Valuation
PE Ratio
PEG Ratio
Price to Book value
Price to Sales
Price to Cash Flow
Stock Dividends
Dividend Yield
Dividend Growth

Stoxline Lite

Stoxline Pro

Stock Chart

Option Calculator